C152H173F3N48O12 — CID 160964701
3-(cyclopropanecarbonylamino)-1-[1-[(4-imidazol-1-ylphenyl)methyl]-4-(isocyanomethyl)piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[(4-pyrazol-1-ylphenyl)methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[(4-pyrrolidin-1-ylphenyl)methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[[4-[1-(trifluoromethyl)pyrazol-3-yl]phenyl]methyl]piperidin-4-yl]pyrazole-4-carboxamide (PubChem CID 160964701) has the molecular formula C152H173F3N48O12 and a molecular weight of 2921.37 g/mol. Its IUPAC name is 3-(cyclopropanecarbonylamino)-1-[1-[(4-imidazol-1-ylphenyl)methyl]-4-(isocyanomethyl)piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[(4-pyrazol-1-ylphenyl)methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[(4-pyrrolidin-1-ylphenyl)methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[[4-[1-(trifluoromethyl)pyrazol-3-yl]phenyl]methyl]piperidin-4-yl]pyrazole-4-carboxamide.
| Compound Name | 3-(cyclopropanecarbonylamino)-1-[1-[(4-imidazol-1-ylphenyl)methyl]-4-(isocyanomethyl)piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[(4-pyrazol-1-ylphenyl)methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[(4-pyrrolidin-1-ylphenyl)methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[[4-[1-(trifluoromethyl)pyrazol-3-yl]phenyl]methyl]piperidin-4-yl]pyrazole-4-carboxamide |
|---|---|
| PubChem CID | 160964701 |
| Molecular Formula | C152H173F3N48O12 |
| Molecular Weight | 2921.37 g/mol |
| Exact Mass | 2919.44 |
| IUPAC Name | 3-(cyclopropanecarbonylamino)-1-[1-[(4-imidazol-1-ylphenyl)methyl]-4-(isocyanomethyl)piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[(4-pyrazol-1-ylphenyl)methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[(4-pyrrolidin-1-ylphenyl)methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]piperidin-4-yl]pyrazole-4-carboxamide;3-(cyclopropanecarbonylamino)-1-[4-(isocyanomethyl)-1-[[4-[1-(trifluoromethyl)pyrazol-3-yl]phenyl]methyl]piperidin-4-yl]pyrazole-4-carboxamide |
| SMILES | [C-]#[N+]CC1(n2cc(C(N)=O)c(NC(=O)C3CC3)n2)CCN(Cc2ccc(-c3ccn(C(F)(F)F)n3)cc2)CC1.[C-]#[N+]CC1(n2cc(C(N)=O)c(NC(=O)C3CC3)n2)CCN(Cc2ccc(-c3ccn(C)n3)cc2)CC1.[C-]#[N+]CC1(n2cc(C(N)=O)c(NC(=O)C3CC3)n2)CCN(Cc2ccc(-n3cccn3)cc2)CC1.[C-]#[N+]CC1(n2cc(C(N)=O)c(NC(=O)C3CC3)n2)CCN(Cc2ccc(-n3ccnc3)cc2)CC1.[C-]#[N+]CC1(n2cc(C(N)=O)c(NC(=O)C3CC3)n2)CCN(Cc2ccc(-n3cncn3)cc2)CC1.[C-]#[N+]CC1(n2cc(C(N)=O)c(NC(=O)C3CC3)n2)CCN(Cc2ccc(N3CCCC3)cc2)CC1 |
| InChI | InChI=1S/C26H27F3N8O2.C26H30N8O2.C26H33N7O2.2C25H28N8O2.C24H27N9O2/c1-31-16-25(37-15-20(22(30)38)23(34-37)32-24(39)19-6-7-19)9-12-35(13-10-25)14-17-2-4-18(5-3-17)21-8-11-36(33-21)26(27,28)29;1-28-17-26(34-16-21(23(27)35)24(31-34)29-25(36)20-7-8-20)10-13-33(14-11-26)15-18-3-5-19(6-4-18)22-9-12-32(2)30-22;1-28-18-26(33-17-22(23(27)34)24(30-33)29-25(35)20-6-7-20)10-14-31(15-11-26)16-19-4-8-21(9-5-19)32-12-2-3-13-32;1-27-17-25(33-16-21(22(26)34)23(30-33)29-24(35)19-5-6-19)9-13-31(14-10-25)15-18-3-7-20(8-4-18)32-12-2-11-28-32;1-27-16-25(33-15-21(22(26)34)23(30-33)29-24(35)19-4-5-19)8-11-31(12-9-25)14-18-2-6-20(7-3-18)32-13-10-28-17-32;1-26-14-24(33-13-20(21(25)34)22(30-33)29-23(35)18-4-5-18)8-10-31(11-9-24)12-17-2-6-19(7-3-17)32-16-27-15-28-32/h2-5,8,11,15,19H,6-7,9-10,12-14,16H2,(H2,30,38)(H,32,34,39);3-6,9,12,16,20H,7-8,10-11,13-15,17H2,2H3,(H2,27,35)(H,29,31,36);4-5,8-9,17,20H,2-3,6-7,10-16,18H2,(H2,27,34)(H,29,30,35);2-4,7-8,11-12,16,19H,5-6,9-10,13-15,17H2,(H2,26,34)(H,29,30,35);2-3,6-7,10,13,15,17,19H,4-5,8-9,11-12,14,16H2,(H2,26,34)(H,29,30,35);2-3,6-7,13,15-16,18H,4-5,8-12,14H2,(H2,25,34)(H,29,30,35) |
| InChIKey | SXLRBSZYQBJMNN-UHFFFAOYSA-N |
| XLogP | 15.74 |
| TPSA | 690.89 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 42 |
| Rotatable Bonds | 48 |
| Heavy Atoms | 215 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2921.37 |
| LogP ≤ 5 | 15.74 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 42 |
| Structural Alerts | {'alert_name': 'anil_di_alk_D(198)', 'substructure': 'N/A'}, {'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|